Nordea Investment Management
RCKT icon

Nordea Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Nordea Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-263,746
Closed -$659K – 878
2025
Q2 		$659K Buy
263,746
+9,341
+4% +$47.3K ﹤0.01% 843
2025
Q1 		$1.67M Buy
254,405
+127,135
+100% +$1.26M ﹤0.01% 723
2024
Q4 		$1.6M Buy
127,270
+501
+0.4% +$7.54K ﹤0.01% 722
2024
Q3 		$2.35M Sell
126,769
-5,717
-4% -$117K ﹤0.01% 665
2024
Q2 		$2.76M Sell
132,486
-21,584
-14% -$496K ﹤0.01% 641
2024
Q1 		$4.14M Buy
154,070
+1,209
+0.8% +$34.3K ﹤0.01% 582
2023
Q4 		$4.66M Sell
152,861
-5,710
-4% -$126K 0.01% 539
2023
Q3 		$3.25M Sell
158,571
-4,201
-3% -$76.4K ﹤0.01% 610
2023
Q2 		$3.33M Sell
162,772
-54,294
-25% -$1.1M ﹤0.01% 603
2023
Q1 		$3.62M Sell
217,066
-21,768
-9% -$426K 0.01% 584
2022
Q4 		$4.65M Sell
238,834
-6,803
-3% -$125K 0.01% 535
2022
Q3 		$3.71M Sell
245,637
-1,131
-0.5% -$17.6K 0.01% 587
2022
Q2 		$3.11M Sell
246,768
-25,963
-10% -$310K ﹤0.01% 635
2022
Q1 		$4.46M Buy
272,731
+2,927
+1% +$50.6K 0.01% 608
2021
Q4 		$6.23M Sell
269,804
-2,464
-0.9% -$67.2K 0.01% 540
2021
Q3 		$8.19M Buy
272,268
+92,585
+52% +$3.37M 0.01% 459
2021
Q2 		$7.96M Buy
+179,683
New +$7.8M 0.01% 464

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Nordea Investment Management's RCKT Position: Q3 2025 in Review

Nordea Investment Management sold out of Rocket Pharmaceuticals (RCKT) in Q3 2025, closing a stake of 263,746 shares — an estimated $659K sold.

Nordea Investment Management first reported a position in RCKT in Q2 2021 and held it in 17 quarters. The position peaked at $8.19M in Q3 2021. 173 funds tracked by Wall St. Rank hold RCKT as of Q3 2025.

  • Nordea Investment Management reported no remaining Rocket Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Nordea Investment Management sold 263,746 Rocket Pharmaceuticals shares in Q3 2025, an estimated $659K.
  • Nordea Investment Management first reported a position in Rocket Pharmaceuticals in Q2 2021 and held it in 17 quarters.
  • Nordea Investment Management's Rocket Pharmaceuticals position peaked at $8.19M in Q3 2021.
  • 173 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2025.

Based on Nordea Investment Management's 13F filing for Q3 2025, filed 27 Oct 2025.